Posted On: 11/23/2015 7:55:02 AM
Post# of 72446
Prurisol study randomized and underway 1 month ahead of schedule. 16 weeks to go. 
News out.
Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
Company's Phase 2 Study of Plaque Psoriasis Completes Goal of Randomizing Subjects
http://finance.yahoo.com/news/cellceutix-rece...00762.html
Tic toc Leo, $5+ before the shareholder meeting.
News out.
Cellceutix Receives FDA Orphan Drug Designation for Kevetrin for the Treatment of Retinoblastoma
Company's Phase 2 Study of Plaque Psoriasis Completes Goal of Randomizing Subjects
http://finance.yahoo.com/news/cellceutix-rece...00762.html
Tic toc Leo, $5+ before the shareholder meeting.
(0)
(0)
